Skip to main content
PLOS Global Public Health logoLink to PLOS Global Public Health
. 2026 Jul 9;6(7):e0005818. doi: 10.1371/journal.pgph.0005818

Adherence to National Standard Treatment Guidelines in the management of hypertension and associated factors among healthcare providers at public district hospitals in Dar es Salaam, Tanzania

Gasper Singfrid Mung’ong’o 1,*, Daniel Msilanga 2, Paul Alikado Sabuni 3, Humphrey Godwin Medarakini 4, Gladys Reuben Mahiti 1, Rose Mpembeni 5
Editor: Julia Robinson6
PMCID: PMC13349132  PMID: 42424347

Abstract

Hypertension affects 15–25% of adults in Tanzania, yet fewer than 30% of treated patients achieve blood pressure control. Poor control contributes to stroke, heart failure, and renal disease. The National Standard Treatment Guidelines (NSTGs), 6th edition (2021), provide guidance for management, but healthcare provider adherence to the guidelines remains unclear. A mixed-methods cross-sectional study was conducted at five public district hospitals in Dar es Salaam, Tanzania between 1st April and 31st May 2025. Quantitative data from patient records assessed healthcare provider adherence to pharmacological treatment, complication monitoring, and comorbidity screening, categorized as complete, partial, or non-adherent. Modified Poisson regression identified associated patient and provider factors. Qualitative data from 11 in-depth interviews were thematically analysed to explore barriers and facilitators to adherence. The median age of the 397 patients was 55 years (IQR: 52–61), 79.1% were female, 40.0% had at least one comorbidity, and 65.2% were overweight. Only 26.2% were managed with complete adherence to NSTGs. Higher adherence was associated with follow-up visits (aPR = 5.81; 95% CI: 1.59–21.27), Grade 1 hypertension (aPR = 3.87; 95% CI: 1.99–7.53), Grade 2 hypertension (aPR = 5.06; 95% CI: 1.52–16.73), comorbidities (aPR = 2.35; 95% CI: 1.25–4.41), specialist cadre (aPR = 7.00; 95% CI: 1.05–46.55), and provider experience of 5–10 years (aPR = 3.25; 95% CI: 1.17–9.03) and >10 years (aPR = 3.91; 95% CI: 1.20–12.73). Barriers included outdated guidelines, limited resources, staffing shortages, and inadequate training, while facilitators included mentorship, peer collaboration, accessible guidelines, and continuing medical education. Healthcare provider adherence to NSTGs in management of hypertension was low. Strengthening guideline implementation through updated recommendations, provider training, improved resource availability, and supportive supervision may enhance adherence and improve patient outcomes.

Introduction

Hypertension remains a major global public health challenge and one of the leading causes of mortality and disability worldwide. The number of people living with hypertension has doubled from an estimated 650 million in 1990 to 1.3 billion by 2019 [1,2]. Despite the global efforts, hypertension control rates remain alarmingly low, with approximately 23% of individuals on treatment achieving adequate blood pressure control [2].

In Tanzania, the burden of NCDs has grown steadily over the past decades. NCDs accounted for 19% of total DALYs in 1990, rising to 34% by 2015, and currently contribute to nearly one-third of all deaths, with a substantial proportion occurring prematurely between ages 30 and 70 [3,4]. Furthermore, among patients on treatment less than 30% attain target blood pressure levels, placing them at substantial risk for life-threatening complications and premature mortality [4,5,6,7].

Recognizing these trends, Tanzania’s National Strategic Plan for the Prevention and Control of Non-Communicable Diseases (2021–2026) identifies hypertension control as a national priority and aligns with both the Health Sector Strategic Plan V and the Universal Health Coverage agenda. A key strategy within this framework is the standardization of care given to patients with Hypertension [8].

The National Standard Treatment Guidelines (NSTGs) 6th edition developed by the Ministry of Health in 2021, provide evidence-based guidance for the diagnosis and management of hypertension in Tanzania [9,10]. However, the extent of healthcare provider adherence to the NSTGs in the management of hypertension remains unclear. Therefore, this study aimed to evaluate adherence to the NSTGs among healthcare providers in public district hospitals in Dar es Salaam. The study also aimed to identify patient- and provider-related factors associated with adherence, as well as the barriers and facilitators influencing healthcare providers’ adherence to the NSTGs in management of Hypertension.

Materials and methods

Study design

A cross-sectional study design employing a convergent parallel mixed-methods approach. The quantitative component assessed the level of healthcare provider adherence to the NSTGs and identified statistically associated provider- and patient-related factors, while the qualitative component explored the barriers and facilitators influencing this adherence. The findings from both components were analyzed separately and integrated during interpretation.

Study area

The study was carried out at five public district hospitals in Dar Es Salaam region one from each district. These are: Kivule district hospital (Ilala), Ubungo district hospital (Ubungo), Mbagala rangi tatu hospital (Temeke), Kigamboni district hospital (Kigamboni) and Mabwepande district hospital (Kinondoni). These hospitals are located in Dar Es Salaam, an urban setting where there is a growing population of patients with Hypertension and hence an appropriate setting to evaluate healthcare provider adherence to the NSTGs in management of these patients [11].

Study population

The study population included patients diagnosed with hypertension who attended outpatient clinics at the study facilities between 1 January and 31 December 2024, and healthcare providers of all cadres involved in prescribing and managing hypertension. Quantitative data were extracted from patient records, while qualitative data were collected through in-depth interviews with healthcare providers. Both quantitative data extraction and qualitative interviews were conducted at the study facilities between 1 April and 31 May 2025.

Inclusion and exclusion criteria

  1. Inclusion criteria

    • i. Patients with Hypertension who were attended from January 2024 to December 2024 at the selected public district hospitals and have case file.

    • ii. Healthcare providers in the public district hospitals who take part in the management of patients with hypertension and agreed to be part of the study

  2. Exclusion criteria

    • i. Patients with case files that do not have a documented diagnosis and management provided between January 2024 and December 2024.

    • ii. Healthcare providers with less than one year of experience working in the selected hospitals as they have limited exposure to the Tanzanian health system and the NSTGs.

Sample size and sampling procedures

For the quantitative analysis, all eligible records of patients with hypertension from January to December 2024 were included using a census approach to maximize statistical power and minimize selection bias; therefore, no prior minimum sample size was calculated. Duplicate entries were identified using unique Medical Record Numbers and removed to ensure that each patient contributed only once to the dataset.

For the qualitative component, eleven healthcare providers participated in in-depth interviews. Sampling followed the principle of data saturation. After the ninth interview, no new themes emerged, and two additional interviews were conducted to confirm thematic stability. By the eleventh interview, redundancy was reached, indicating sufficient depth and breadth of data across provider cadres and facility contexts.

Patient data were extracted from the Government of Tanzania Hospital Management Information System (GOTHOMIS) outpatient department registers. Providers were selected purposively based on their direct involvement in hypertension management at either Non-Communicable Disease (NCD) clinics or general outpatient departments. Only those with at least one year of service and who gave written informed consent to participate were included.

Study variables

The dependent variable was healthcare provider adherence to NSTGs in hypertension management, measured through a structured checklist applied to retrospective patient records covering the three months preceding the most recent clinic visit.

Adherence was assessed in three domains:

  1. Pharmacological management: Consistency of prescribed antihypertensive medications with NSTG recommendations based on patient classification, comorbidities, and crisis status.

  2. Monitoring for complications: Performance of recommended investigations such as ECG, echocardiography, renal function tests, urinalysis, fundoscopy, and relevant laboratory tests.

  3. Screening for comorbidities: Screening for diabetes mellitus, dyslipidemia, and obesity through glucose tests, lipid profiles, and BMI assessment.

Each item was scored dichotomously (1 = adherent, 0 = non-adherent). The adherence score was computed as a percentage of total possible points. Independent variables included patient characteristics (age, sex, BMI, payment mode, visit type, hypertension grade, comorbidities) and provider characteristics (age, sex, professional cadre, years of experience, and facility).

The qualitative component explored barriers and facilitators influencing provider adherence to NSTGs.

Quantitative data collection.

Data were collected by the principal investigator using a structured digital checklist developed on the Open Data Kit (ODK) a free, open-source mobile data collection platform. Eligible records for patients with Hypertension were identified via GOTHOMIS registers and verified through NCD clinic and laboratory registers. The checklist captured patient demographics, clinical characteristics, investigations, and treatment in line with NSTG recommendations. Data were entered in real time into the Open Data Kit (ODK) platform and securely uploaded to a central server for analysis.

Qualitative data collection.

In-depth interviews were conducted in Swahili by the principal investigator using a structured guide. All interviews were audio-recorded and supplemented with detailed field notes capturing non-verbal cues and contextual observations. Recordings were transcribed verbatim and translated into English by trained bilingual research assistants.

Data management

Audio recordings were stored securely on password-protected Google Drive folders accessible only to the investigator. Transcripts were anonymized before translation. Quantitative data extracted from Open Data Kit (ODK) were exported to Microsoft Excel and stored in encrypted drives before analysis in Stata version 17. Regular backups were maintained to ensure data security and integrity.

Validity and reliability

The quantitative data collection tool was developed based on the 6th Edition NSTGs and reviewed by two clinical experts (a nephrologist and an emergency physician) for content validity. The tool was pretested on 50 files of patients with Hypertension at a private outpatient clinic to assess clarity and usability, leading to minor revisions. Face validity was confirmed by three independent medical practitioners who reviewed the final checklist for relevance and comprehensiveness.

Trustworthiness

Trustworthiness was ensured through the application of four key criteria. Credibility was enhanced by prolonged engagement of principal investigator in the field, peer debriefing, and triangulation with observational data to ensure accurate representation of participants’ views. Transferability was supported through rich, detailed descriptions of the study context and participant selection, enabling readers to assess the applicability of the findings to other settings. Dependability was maintained by establishing an audit trail that documented all methodological steps, ensuring consistency and replicability of the research process. Finally, confirmability was achieved through peer debriefing and member checking, which helped minimize researcher bias and ensure that the findings accurately reflected participants’ perspectives.

Data analysis

Data were analyzed using Stata version 17. Descriptive statistics summarized participant characteristics: means and standard deviations for normally distributed variables, medians and interquartile ranges for skewed data, and frequencies and proportions for categorical variables.

Adherence scores were calculated using:

Adherence score= (Points scored/Total points available)×100%

Scores were categorized as complete (≥65%), partial (50–64.9%), or non-adherent (<50%), consistent with prior regional studies that assessed composite provider adherence to hypertension guidelines using similarly structured multi-domain checklists in comparable sub-Saharan African settings [12–14].

Bivariate analyses were conducted to identify variables significantly associated with adherence (p < 0.05). These variables, along with age and sex, were included in the multivariable model. Statistical significance was defined as p < 0.05.

Qualitative data analysis

Thematic analysis was conducted using ATLAS.ti (version 22) - a qualitative data analysis software. Transcripts were read repeatedly to ensure familiarity with the data. Relevant statements were coded inductively, grouped into subthemes, and then aggregated into major themes representing barriers and facilitators to adherence. Coding and theme development were iterative, with continuous comparison to ensure internal coherence and alignment with study objectives.

Ethical issues

Ethical approval was obtained from the Muhimbili University of Health and Allied Sciences (MUHAS) Research and Publications Committee (approval number DA.282/298/01.C/2694) on 11 March 2025. Administrative permission was granted by the Regional Medical Officer, District Medical Officers, and facility leadership. Written informed consent was obtained from all healthcare providers who participated in the in-depth interviews.

During data collection, the research team accessed patient medical records containing identifiable information. However, no personal identifiers were recorded or retained. Patient data were anonymized at the point of extraction, and individuals were identified only using unique medical record numbers for study purposes. Confidentiality was ensured through anonymization of data and secure data handling procedures.

Results

Patient characteristics

A total of 474 case files with unique medical record numbers of patients with Hypertension attended at the public district hospitals from January 2024 to December 2024 were obtained from the GOTHOMIS OPD registers. Of these, 397 case files (83.8%) contained complete information required for inclusion. The enrollment process is reflected in Fig 1.

Fig 1. Enrollment of case files in the study.

Fig 1

The median age of patients was 55 years (IQR: 52–61), with the majority (233; 58.7%) aged 45–60 years, and 39 patients (9.8%) aged below 45 years. Most patients were female (314; 79.1%). The mean body mass index (BMI) was 27.34 kg/m² (SD: 3.08), with 259 (65.2%) overweight and 81 (20.4%) obese. Regarding payment mode, 265 patients (66.8%) paid out-of-pocket, while 71 (17.9%) were covered by national health insurance. Follow-up visits accounted for 353 (88.9%) of encounters. Blood pressure control was achieved in 166 patients (41.8%), while 21 (5.3%) presented in hypertensive crisis. The median number of antihypertensive drugs used was 2 (range 1–4), with 268 patients (67.5%) using more than one drug. Comorbidities were present in 159 patients (40.0%), with obesity (20.4%) and diabetes mellitus (15.1%) being most common. These are displayed on Table 1.

Table 1. Demographic and clinical characteristics of the patients (n = 397).

Variable Number Percentage
Age (median, IQR) 55, 52-61
Age group
 Less than 45 39 9.8%
 45-60 232 58.4%
 Above 60 126 31.7%
Sex
 Female 314 79.1%
 Male 83 20.9%
Body mass index (mean, SD) 27.34, 3.083
Body mass index category
 Normal 57 14.4%
 Overweight 259 65.2%
 Obese 81 20.4%
Payment mode
 National health insurance 71 17.9%
 Government exception 24 6.1%
 iCHF 37 9.3%
 Cash 265 66.8%
Type of the visit
 New case 44 11.1%
 Follow up visit 353 88.9%
Grade of hypertension
 Controlled 166 41.8%
 Grade 1 188 47.4%
 Grade 2 22 5.5%
 Grade 3 21 5.3%
Hypertensive crises
 Not in crisis 376 94.7%
 Hypertension emergency 14 3.5%
 Hypertension urgency 7 1.8%
Number of antihypertensives (median, range) 2, 1-4
Number of antihypertensives
 One 129 32.5%
 More than one 268 67.5%
Comorbidity condition
 No 238 60.0%
 Yes 159 40.0%
Types of comorbidity condition Ϯ (n = 397)
 Diabetes 60 15.1%
 Heart failure 35 8.8%
 Pregnancy induced 17 4.3%
 Asthma 21 5.3%
 Arrhythmias 9 2.3%
 Dyslipidemias 26 6.5%
 Obesity 81 20.4%

Hints: Ϯ = multiple response.

Healthcare provider characteristics

A total of 26 healthcare providers who attended patients with hypertension included in the study were recruited from five district hospitals (Table 2). Kigamboni, Kivule, and Mabwepande each contributed four providers, while Mbagala Rangi Tatu and Ubungo each contributed seven. The mean age of the providers was 36.25 years (SD = 8.45), with the majority aged 21–30 years (n = 12). Females (n = 15) outnumbered males. The most common professional cadre was medical doctor (n = 16), while specialists were few (n = 3). The mean duration of work experience was 6.69 years (SD = 3.61), with most providers having less than five years of experience (n = 12). These are displayed on Table 2.

Table 2. Demographic characteristics of the healthcare providers (n = 26).

Variable Number of healthcare providers
Facility name
 Kigamboni district hospital 4
 Kivule district hospital 4
 Mabwepande district hospital 4
 Mbagala rangi tatu hospital 7
 Ubungo district hospital 7
Age (mean, SD) 36.25, 8.449
Age group
 21-30 12
 31-40 8
 Above 40 6
Sex
 Male 11
 Female 15
Cadre
 Clinical officer 4
 Assistant medical officers 3
 Medical doctor 16
 Specialist 3
Working experience (mean years, SD) 6.69, 3.610
 Less than 5 years 12
 5–10 years 10
 More than 10 years 4

For the qualitative part of the study, In depth interviews were conducted with 11 healthcare providers: 4 clinical officers, 2 assistant medical officers (AMOs), 4 medical doctors (MDs), and one specialist (physician).

Fig 2 shows the level of adherence of healthcare providers to the guidelines in management of Hypertension.

Fig 2. Healthcare provider adherence to NSTGs in management of Hypertension.

Fig 2

Level of adherence of the healthcare providers

Patient factors associated with adherence of healthcare providers.

Modified Poisson regression revealed that follow-up visits were significantly associated with guideline-concordant management compared to new cases (aPR = 5.81; 95% CI: 1.59–21.27; p = 0.008). Higher grades of hypertension were also positively associated with adherence, including Grade 1 (aPR = 3.87; 95% CI: 1.99–7.53, p < 0.001) and Grade 2 (aPR = 5.06; 95% CI: 1.52–16.73, p = 0.008). Presence of comorbidities was significantly associated with a higher prevalence of guideline-concordant management (aPR = 2.35; 95% CI: 1.25–4.41; p = 0.008).

Table 3 shows the patient factors and their association to healthcare provider adherence to the guidelines.

Table 3. Patient factors associated with adherence of healthcare providers to the NSTGs in the management of hypertension.
Variable Total Adherence status Unadjusted PR δ Adjusted PR δ
No

n (%)
Yes

n (%)
PR, 95% CI p-value PR, 95% CI p-value
Age group
 Less than 45 39 32 (82.1) 7 (18.0) 1 1
 45-60 232 171 (73.7) 61 (26.3) 1.37, 0.53–3.53 0.515 0.84, 0.27–2.61 0.766
 Above 60 126 90 (71.4) 36 (28.6) 1.60, 0.59–4.29 0.348 0.59, 0.17–2.03 0.406
Sex
 Female 314 231 (73.6) 83 (26.4) 1 1
 Male 83 62 (74.7) 21 (25.3) 0.98, 0.53–1.81 0.952 1.47, 0.71–3.08 0.302
Body mass index category
 Normal 57 40 (70.2) 17 (29.8) 1
 Overweight 259 201 (77.6) 58 (22.4) 0.68, 0.33–1.39 0.289
 Obese 81 52 (64.2) 29 (35.8) 126, 0.55–2.88 0.577
Payment mode
 Cash 265 204 (77.0) 61 (23.0) 1
 Insurance 132 89 (67.4) 43 (32.6) 1.31, 0.77–2.23 0.315
Type of the visit
 New case 44 40 (90.9) 4 (9.1) 1 1
 Follow up visit 353 253 (71.7) 100 (28.3) 3.23, 1.07–9.78 0.038 5.81, 1.59–21.27 0.008
Grade of hypertension
 Controlled 166 139 (83.7) 27 (16.3) 1 1
 Grade 1 188 131 (69.7) 57 (30.3) 3.21, 1.77–5.84 <0.001 3.87, 1.99–7.53 <0.001
 Grade 2 22 12 (54.6) 10 (45.5) 5.27, 1.81–15.33 0.002 5.06, 1.52–16.73 0.008
 Grade 3 21 11 (52.4) 10 (47.6) 3.88, 1.33–11.30 0.013 2.78, 0.76–10.13 0.122
Comorbidity condition
 No 238 194 (81.5) 44 (18.5) 1 1
 Yes 159 99 (62.3) 60 (37.7) 2.98, 1.75–5.08 <0.001 2.35, 1.25–4.41 0.008

Hints: PR = Prevalence Ratio; 95% CI = 95 percent confidence interval; δ = Adjusted by cluster, i.e., healthcare providers; sigma_u = 0.993; rho = 0.23, chi = 30.95 (p < 0.001).

Healthcare providers’ factors associated with adherence

Provider cadre and experience influenced adherence. Specialists demonstrated significantly higher adherence compared to clinical officers (aPR = 7.00; 95% CI: 1.05–46.55; p = 0.004). Providers with 5–10 years of experience (aPR = 3.25; 95% CI: 1.17–9.03; p = 0.024) and more than 10 years of experience (aPR = 3.91; 95% CI: 1.20–12.73; p = 0.023) were also more likely to adhere. Age and sex showed no significant association after adjustment. Table 4 presents provider-related factors associated with adherence.

Table 4. Healthcare providers’ factors associated with adherence of healthcare providers to the NSTGs in the management of hypertension (n = 397).

Variable Total patient attended Adherence status Unadjusted PR δ Adjusted PR δ
No

n (%)
Yes

n (%)
PR, 95% CI p-value PR, 95% CI p-value
Age group
 21-30 140 120 (85.7) 20 (14.3) 1 1
 31-40 158 100 (63.3) 58 (36.7) 2.92, 1.08–7.86 0.034 0.48, 0.15–1.52 0.214
 Above 40 99 73 (73.7) 26 (26.3) 2.21, 0.76–6.51 0.147 0.86, 0.30–2.47 0.783
Sex
 Male 160 117 (73.1) 43 (26.9) 1 1
 Female 237 176 (74.3) 61 (25.7) 0.79, 0.29–2.07 0.624 1.28, 0.70–2.31 0.422
Cadre
 Clinical officer 23 21 (91.3) 2 (8.7) 1 1
 Assistant medical officers 39 34 (87.2) 5 (12.8) 1.56, 0.25–9.76 0.637 0.64, 0.09–4.27 0.645
 Medical doctor 237 191 (80.6) 46 (19.4) 2.45, 0.51–11.69 0.262 1.48, 0.31–7.04 0.624
 Specialist 98 47 (48.0) 51 (52.0) 11.66, 2.31–58.99 0.002 7.00,1.05–46.55 0.004
Working experience (mean years, SD)
 Less than 5 years 144 128 (88.9) 16 (11.1) 1 1
 5–10 years 177 117 (66.1) 60 (33.9) 3.45, 1.41–8.37 0.006 3.25, 1.17–9.03 0.024
 More than 10 years 76 48 (63.2) 28 (36.8) 4.70, 1.61–13.73 0.005 3.91, 1.20–12.73 0.023

Hints: PR = Prevalence Ratio; 95% CI = 95 percent confidence interval; δ = Adjusted by cluster, i.e., patient attended.

For the qualitative component, 11 healthcare providers were selected using purposive sampling based on cadre diversity, years of experience, and direct involvement in hypertension care, and recruitment continued until data saturation was reached.

Barriers that influence healthcare provider adherence

Several barriers affecting healthcare provider adherence to the NSTGs in the management of hypertension emerged from the interviews. These barriers were grouped into four main themes: guideline-related, resource-related, provider-related, and patient-related barriers.

Guideline-related barriers.

Providers perceived the NSTGs as outdated noting that newer medications are not included and updates occur infrequently. As one provider explained, “Some things in the STG are outdated. Many new drugs exist but aren’t in the STG. A patient comes with a drug, you check the STG, it’s not there, yet it’s effective” (Medical Doctor). Participants suggested that guideline revisions should occur more frequently and be informed by locally generated evidence. One specialist noted, “They should update the STG earlier. Waiting four or five years is too long… at least every two to three years” (Specialist Physician).

Providers also highlighted limited guidance for managing hypertension with comorbidities, stating that some clinical scenarios are insufficiently addressed. “The management is generalized… for hypertension and diabetes it’s explained, but for other categories the steps are not clear” (Medical Doctor). Additionally, participants emphasized the need for greater involvement of frontline healthcare workers during guideline development to ensure recommendations are feasible in district hospital settings. “STG development should involve users more… some things written in the STG, district hospitals can’t achieve due to limited resources” (Medical Doctor).

Policy-related prescribing restrictions were also reported to limit adherence in some cases, particularly when medications initiated by specialists could not be continued by providers at lower levels. “Some drugs require a physician to prescribe… a patient may come already started on medication by a specialist, but here I can’t prescribe it” (Medical Doctor). Providers further suggested that regular supervision could help reinforce guideline use.

Resource barriers.

Limited availability of medications recommended in the NSTGs was frequently reported, particularly for hypertensive emergencies. One participant explained, “IV medications, honestly, if you get them, it’s by luck. Hydralazine you might get by luck, labetalol there’s none… you have to mix and match” (Assistant Medical Officer).

Shortages of diagnostic equipment and laboratory services also hindered guideline adherence. Providers described inadequate blood pressure monitoring equipment and limited access to investigations required for appropriate management. “We have just one BP machine running around… tests for renal failure aren’t done yet because the lab isn’t fully operational” (Medical Doctor).

In addition, specialized investigations such as echocardiography, ECG, and fundoscopy were often unavailable at district hospitals, requiring referrals to higher-level facilities. “For ECHO and ECG tests we send patients to the regional hospital… our hospital still doesn’t have the capacity” (Specialist Physician). Heavy patient loads and limited bed capacity further constrained the ability to manage patients according to guideline recommendations.

Provider-related barriers.

Participants reported limited formal training on the NSTGs, which affected familiarity with the guidelines. One provider noted, “Two or three doctors were taken for training in Dodoma… but I’ve never seen if they came back with a guideline” (Assistant Medical Officer). High staff turnover further reduced knowledge retention, as trained providers were often transferred to other facilities. “Of those doctors who went for training, only one has remained… the others were transferred, so the knowledge is lost” (Assistant Medical Officer).

Some providers also reported relying primarily on clinical experience rather than consulting the guidelines directly. As one participant stated, “Blood pressure medications are well known; it’s almost routine… to say I refer to the guideline when seeing a patient—rarely” (Medical Doctor).

Patient-related barriers.

Financial constraints among patients were commonly reported to affect adherence to recommended investigations and medications. “Tests for patients with hypertension and other NCDs are very costly… the challenge comes when you need to move a patient to more advanced, expensive drugs” (Medical Doctor).

Limited patient health literacy was also identified as a challenge, with some patients failing to fully understand their condition or the importance of treatment adherence. “You may educate them and prescribe treatment, but on the next visit you find complications because they only bought a few of the medicines” (Clinical Officer). Providers further emphasized the need for improved community awareness about hypertension and its risk factors. “Many lack knowledge… even older patients don’t realize age itself is a risk for hypertension” (Medical Doctor).

Facilitators that enhance adherence

Supportive practices and resources.

Providers highlighted peer support, mentorship, and CME sessions as key facilitators.

Structured CME sessions and mentorship reinforced adherence. “For training, we sometimes have doctors from programs like Mama Samia’s on-job training or from other facilities, which is good. We’ve learned a lot from Mama Samia’s program, where specialists come to mentor us. We ask questions, see where we’re going wrong, and improve… You can also learn on the job or visit other facilities to see how they treat patients and run their clinics” (Medical Doctor).

Another provider added, “Yes, we have CME every Tuesday. We have different departments, and the presentations vary. For example, OPD might present on hypertension or malaria on a given Tuesday. First, it helps you not forget things. You might forget something, but the NSTGs helps in treating the patient properly, especially with dosage—someone might forget, or in an emergency, you can refer to it, and the patient gets the right treatment” (Assistant Medical Officer).

On-the-job training was also valued: “Yes, I’ve had on job training. When you encounter a case and a senior doctor explains it to you, that’s on job training. If you see a similar patient the next day, you know where to start” (Clinical Officer).

Digital access to the NSTGs in the management of Hypertension was noted as helpful: “I have a hardcopy, I was given one…but the online one is available, you can open GOTHOMIS and on the side open the STG because it’s there, if you search for it on the computer, it comes up. The challenges I see: first, availability of resources. Hard copies are scarce, so soft copies are needed since they’re quicker to access, especially with many patients” (Specialist Physician).

Discussion

This study revealed that only 26.2% of patients with Hypertension at public district hospitals in Dar es Salaam received management that was completely adherent to the NSTGs consistent with evidence from Dodoma where 29.29% of patients received guideline-concordant management across all conditions [15]. This reflects systemic challenges across public health facilities in Tanzania that hinder consistent application of standardized protocols.

Comparable trends have been observed in other sub-Saharan African settings, including Ethiopia (19.5%), Ghana (30%), and Zimbabwe (35%) [13,16,17], these can be explained by inadequate provider training and resource limitations. Conversely, higher adherence in better-resourced tertiary hospitals, such as 67.1% in Nigeria, underscores the critical role of institutional support, continuous professional development, and resource availability in facilitating evidence-based practice [18].

Our findings indicate that patients attending follow-up visits were markedly more likely to receive guideline-concordant care, aligning with evidence from the United States and Indonesia that ongoing care enhances patients’ health literacy, thereby supporting consistent guideline application [19,20]. Regular clinic visits likely allow providers to build familiarity with patients’ treatment plans, facilitating adherence, whereas initial consultations may challenge guideline application due to incomplete patient histories. Similarly, the presence of comorbidities roughly doubled the likelihood of guideline-concordant management, consistent with a finding in South Africa for patients with Hypertension comorbid with Diabetes Mellitus [12].

Furthermore, adherence was higher in the management of patients with Grade 1 and Grade 2 hypertension compared with controlled patients, although adherence for Grade 3 hypertension was not statistically significant, likely due to the smaller number of patients in this category. This pattern suggests that providers may be more likely to follow guideline recommendations when managing patients with evident hypertension severity, while lower adherence in controlled cases may reflect therapeutic inertia, where treatment adjustments are less aggressively pursued despite ongoing guideline recommendations.

In this study healthcare provider adherence was not associated with patient age, sex, nor mode of payment. This contrasts with a study in the United States which suggested that demographic factors like age and gender may necessitate deviations from guidelines due to individualized needs [21].

Specialists showed a sevenfold higher prevalence of complete adherence compared to clinical officers, consistent with studies in Nigeria [18] and Malaysia [22] linking provider knowledge to guideline adherence [21,23]. Their advanced training and exposure to evidence-based practices could enable more accurate application of the NSTGs, whereas clinical officers, who may have less formal training, might rely more on informal mentorship, as suggested by the qualitative data. The wide confidence interval suggests limited precision, possibly due to small subgroup sizes, highlighting the need for larger studies to confirm this effect.

Providers with five or more years of experience showed 3–4-fold higher adherence compared to those with less than five years, consistent with a study in Sudan linking adherence to clinical experience [24], but contrasting a study in United States where less experienced providers relied heavily on guidelines [21]. In Dar es Salaam, experienced providers likely develop practical skills enabling better NSTG application, while newer providers face challenges due to limited training.

Guideline-related factors emerged as significant barriers. Providers reported that the current edition of NSTGs is outdated, lacking updated drug regimens and protocols, and provided limited guidance for managing comorbidities, compelling reliance on clinical judgment or external references. The limited involvement of frontline providers in guideline development further reduced relevance to local practice, echoing findings from Zimbabwe that inclusive guideline development enhances adherence [25]. Resource constraints, including persistent drug shortages, malfunctioning or unreliable blood pressure monitors, and frequent stock-outs of essential supplies, substantially hindered consistent application of the NSTGs. These challenges were compounded by high patient volumes and heavy workloads, which limited the time healthcare providers could dedicate to thorough clinical assessment and documentation. Inadequate supervision and irregular clinical audits further weakened accountability and opportunities for feedback, leading to variability in practice and reduced motivation to adhere strictly to guidelines.

The systemic and structural barriers identified in this study mirror broader evidence from sub-Saharan Africa, where the absence of supportive health system environments, including adequate staffing, continuous supervision, and reliable resources, has been shown to undermine adherence to standard treatment guidelines. Key challenges include inadequate staffing, insufficient supervision, and unreliable availability of essential resources, which collectively reduce the quality of hypertension care. These obstacles contribute to poor detection, treatment, and control rates, while reliance on data from non-native populations may further limit treatment effectiveness. [23,24,26–29].

Socioeconomic factors, including high out-of-pocket costs and low health literacy, also contributed to deviations from recommended care, underscoring the influence of patient context on provider adherence. Similar observations were reported in Zimbabwe, where financial barriers and limited awareness hindered blood pressure control [25], and in Nigeria, where inadequate insurance coverage and poor understanding of hypertension reduced quality of care [23]. Studies from Ghana and Tanzania further highlight that limited patient knowledge and poor facility preparedness continue to impede effective hypertension management [26,30].

Facilitators of adherence included peer support and mentorship, access to digital NSTGs, and CME sessions, which enhanced guideline use even in resource-limited settings. Providers highlighted that peer consultation and informal mentorship helped in complex cases, while digital copies allowed rapid reference when hard copies were unavailable. This was similarly observed in Saudi Arabia and Malaysia [31,32].

Overall, these findings indicate that adherence to hypertension management guidelines in Dar es Salaam is shaped by patient complexity, provider expertise, guideline relevance, and systemic factors, including resources, supervision, and workload.

Strengths and limitations of the study

This study has several strengths. Its mixed-methods design, combining retrospective analysis of 397 patient files with 11 in-depth interviews, provides a comprehensive assessment of guideline adherence across five public district hospitals spanning all districts of Dar es Salaam. Data collection used a structured checklist based on the 6th edition NSTGs cross-verified with GOTHOMIS and manual registers, enhancing reliability. Integration of quantitative and qualitative findings further strengthens the credibility and depth of the conclusions.

However, several limitations should be noted. The cross-sectional design prevents causal inference, and focus on urban hospitals limits generalizability to rural settings. Retrospective file review introduced potential inaccuracies, with 16.2% of files excluded due to missing information. Non-pharmacological interventions were frequently under-documented, limiting the scope of adherence assessment. The composite adherence measure used a 65% threshold for complete adherence, adopted from prior regional studies using comparable multi-domain checklists, which may have led to overestimation of complete adherence.

Resource barriers were captured qualitatively through provider interviews rather than a structured facility readiness assessment, which may not fully quantify objective facility-level deficiencies. The qualitative component did not differentiate responses by provider cadre, patient perspectives were not included, and small subgroup sizes resulted in wide confidence intervals for some estimates.

Conclusion and recommendations

Adherence to the NSTGs for hypertension management in public district hospitals in Tanzania remains suboptimal, increasing the risk of preventable complications. Several key barriers and facilitators influencing adherence were identified, spanning guideline-related, resource-related, provider-related, and patient-related factors.

At the policy level, the Ministry of Health should regularly update the NSTGs every two to three years to reflect current evidence and local contexts, with active involvement of frontline providers in guideline development, dissemination, and sensitisation. Incorporating adherence indicators into supportive supervision frameworks and district performance assessments would strengthen accountability. In the longer term, expanding health insurance coverage and introducing subsidy mechanisms for essential diagnostics, medicines, and follow-up services could reduce out-of-pocket costs for patients.

At the facility level, investments in training, infrastructure, supply chain management, and routine clinical audits should be prioritised alongside peer mentorship programmes. Further research should incorporate structured facility readiness assessments tools to objectively quantify resource availability alongside provider-reported experiences, assess adherence in rural and diverse settings, include patient perspectives, and link provider practices to clinical outcomes. Coordinated policy, facility-level, and research efforts are essential to improve guideline adherence and hypertension outcomes nationwide.

Acknowledgments

The authors express their sincere gratitude to all who contributed to the success of this study. We extend our appreciation to the public district hospitals and district municipality authorities for their support and cooperation. We are deeply grateful to all study participants for their invaluable contributions, which were essential to the completion of this research. This study was conducted as part of a Master’s degree in Project Management, Monitoring, and Evaluation in Health at Muhimbili University of Health and Allied Sciences.

Data Availability

Due to ethical restrictions related to patient confidentiality and protection of sensitive personal health information, the datasets generated and/or analyzed during the current study are not publicly available. De-identified quantitative data and relevant excerpts from qualitative interviews are available upon reasonable request and with permission from the MUHAS Research and Publications Committee, which granted ethical approval for this study (approval number DA.282/298/01.C/2694). Data requests may be directed to the MUHAS Research and Publications Committee, Muhimbili University of Health and Allied Sciences, P.O. Box 65001, Dar es Salaam, Tanzania (Email: rpc@muhas.ac.tz; Website: www.muhas.ac.tz). Data will be retained in accordance with MUHAS institutional data management policies ensuring long-term availability to interested researchers.

Funding Statement

The authors received no specific funding for this work.

References

  • 1.World Health Organization. Global Health Estimates 2019: Deaths by cause, age, sex, by country and by region,2000–2019, Geneva, [Internet]. 2020. [cited 2024 Mar 10]. Available from: https://www.who.int/data/global-health-estimates [Google Scholar]
  • 2.Zhou B, Carrillo-Larco RM, Danaei G, Riley LM, Paciorek CJ, Stevens GA, et al. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. 2021;398(10304):957–80. 10.1016/S0140-6736(21)01330-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Ploth DW, Mbwambo J, Fonner VA, Horowitz BZ, Zager P, Schrader R. Prevalence of CKD, diabetes, and hypertension in rural Tanzania. Kidney Int Rep. 2018;3(4):905–15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Muhihi AJ, Anaeli A, Mpembeni RNM, Sunguya BF, Leyna G, Kakoko D. Prevalence, awareness, treatment, and control of hypertension among young and middle-aged adults: results from a community-based survey in rural Tanzania. Int J Hypertens. 2020;2020:1–13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Okello S, Muhihi A, Mohamed SF, Ameh S, Ochimana C, Oluwasanu AO, et al. Hypertension prevalence, awareness, treatment, and control and predicted 10-year CVD risk: a cross-sectional study of seven communities in East and West Africa (SevenCEWA). BMC Public Health. 2020;20(1). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Mwita JM, Nyawale HA, Mghanga FP. The burden of hypertension and its associated factors among adults in Ruvuma, Southern Tanzania. 2020.
  • 7.Aytenew TM, Kassaw A, Simegn A, Nibret Mihretie G, Asnakew S, Tesfahun Kassie Y, et al. Uncontrolled hypertension among hypertensive patients in Sub-Saharan Africa: a systematic review and meta-analysis. PLoS One. 2024;19(6):e0301547. doi: 10.1371/journal.pone.0301547 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Republic U. United Republic of Tanzania National Strategic Plan for Prevention and Control of Non-Communicable Diseases 2021-2026 National Strategic Plan for Non-Communicable Diseases. 2026. [Google Scholar]
  • 9.Urassa DP, Mwangu M, Makwi JK. Utilization of standard treatment guidelines (STG) at primary health facilities, Magu district, Tanzania. East Afr J Public Health. 2013;10(1):238–45. [Google Scholar]
  • 10.National Medicine and Therapeutic Committee. Standard Treatment Guidelines Tanzania. 2021. Available from: https://medicine.st-andrews.ac.uk/igh/wp-content/uploads/sites/44/2022/01/STG-NEMLIT-2021.pdf [Google Scholar]
  • 11.Ministry of Health Tanzania. Hospitals at district level [Internet]. 2024. [cited 2024 Nov 9]. Available from: https://hfrs.moh.go.tz/web/index.php?r=portal%2Fquick-search&filters=HOSD [Google Scholar]
  • 12.Adedeji AR, Tumbo J, Govender I. Adherence of doctors to a clinical guideline for hypertension in Bojanala district, North-West Province, South Africa. Afr J Prim Heal Care Fam Med. 2015;7(1):1–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Ataro BA, Mulatu G, Mengistu D. Compliance with guidelines of hypertension management, and associated factors among the health practitioners. Inquiry. 2023;60. doi: 10.1177/00469580231216400 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Moges TA, Berihun Dagnew S, Zewdu WS, Wondm SA, Tarekegn GY, Mussie DA, et al. Prescribers’ adherence to clinical practice guidelines for the management of hypertension at public hospitals in Northwest Ethiopia: An explanatory sequential mixed-methods study. Sage Open Chronic Dis. 2026;17. doi: 10.1177/27558428261420524 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Wiedenmayer K, Ombaka E, Kabudi B, Canavan R, Rajkumar S, Chilunda F, et al. Adherence to standard treatment guidelines among prescribers in primary healthcare facilities in the Dodoma region of Tanzania. BMC Health Serv Res. 2021;21(1):272. doi: 10.1186/s12913-021-06257-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Basopo V, Mujasi PN. To what extent do prescribing practices for hypertension in the private sector in Zimbabwe follow the national treatment guidelines? An analysis of insurance medical claims. J Pharm Policy Pract. 2017;10:37. doi: 10.1186/s40545-017-0125-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Harrison MA, Marfo AFA, Buabeng KO, Annan A, Nelson F, Boateng DP. Blood pressure—lowering medication prescribing, its adherence to guidelines and relationship with blood pressure control at a family medicine department. Heal Sci Rep. 2023;6(4). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Ibezim IC, Naylor IA, Isah A, Igboeli NU. Adherence to essential hypertension treatment guidelines in a tertiary hospital in Nigeria. Int J Pharm Pharm Sci. 2020:106–10. [Google Scholar]
  • 19.Lu Y. Barriers to optimal clinician guideline adherence in the management of markedly elevated blood pressure: A qualitative content analysis of electronic health records. 2024. [DOI] [PMC free article] [PubMed]
  • 20.Mulyanto J, Kringos DS, Kunst AE. Socioeconomic inequalities in the utilisation of hypertension and type 2 diabetes management services in Indonesia. Trop Med Int Health. 2019;24(11):1301–10. doi: 10.1111/tmi.13303 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Cabezas S, Grant K, Clark J. Evaluating the prescribing patterns of antihypertensive medications in a student-run free clinic. J Student-Run Clin. 2023;9(1). [Google Scholar]
  • 22.Ahmad N, Khan AH, Khan I, Khan A, Atif M. Doctors’ knowledge of hypertension guidelines recommendations reflected in their practice. Int J Hypertens. 2018;2018:8524063. doi: 10.1155/2018/8524063 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Odusola AO, Stronks K, Hendriks ME, Schultsz C, Akande T, Osibogun A, et al. Enablers and barriers for implementing high-quality hypertension care in a rural primary care setting in Nigeria: perspectives of primary care staff and health insurance managers. Glob Health Action. 2016;9:29041. doi: 10.3402/gha.v9.29041 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Abdelgadir HS, Elfadul MM, Hamid NH, Noma M. Adherence of doctors to hypertension clinical guidelines in academy charity teaching hospital, Khartoum, Sudan. BMC Health Serv Res. 2019;19(1):309. doi: 10.1186/s12913-019-4140-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Goverwa TP, Masuka N, Tshimanga M, Gombe NT, Takundwa L, Bangure D, et al. Uncontrolled hypertension among hypertensive patients on treatment in Lupane District, Zimbabwe, 2012. BMC Res Notes. 2014;7:703. doi: 10.1186/1756-0500-7-703 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Boima V, Doku A, Hayfron-Benjamin C, Twumasi AAA, Awuah RB, Selom JE, et al. Level of understanding and community-level barriers to the management of hypertension: a qualitative study in eight coastal communities in Ghana. BMJ Glob Health. 2025;10(8):e017511. doi: 10.1136/bmjgh-2024-017511 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Commodore-Mensah Y, Liu X, Ogungbe O, Ibe C, Amihere J, Mensa M, et al. Design and rationale of the home blood pressure telemonitoring linked with community health workers to improve blood pressure (LINKED-BP) program. Am J Hypertens. 2023;36(5):273–82. doi: 10.1093/ajh/hpad001 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Philbert R, Temba PM, Ebrahim AA, Rusobya H, Mashili F. Hypertension beyond the clinic: patient perspectives on self-management in a resource-limited urban setting. 2025.
  • 29.Jobe M, Beye SM, Gaye ND, Ka MM, Perel P, Perkins AD, et al. Hypertension in Sub-Saharan Africa: burden, barriers and priorities for improving treatment outcomes. Circ Res. 2025;137(1):106–18. doi: 10.1161/CIRCRESAHA.124.323889 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Adinan J, Manongi R, Temu GA, Kapologwe N, Marandu A, Wajanga B, et al. Preparedness of health facilities in managing hypertension & diabetes mellitus in Kilimanjaro, Tanzania: a cross sectional study. BMC Health Serv Res. 2019;19(1):537. doi: 10.1186/s12913-019-4316-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Shnaimer JA, Gosadi IM. Primary health care physicians’ knowledge and adherence regarding hypertension management guidelines in southwest of Saudi Arabia. Medicine (Baltimore). 2020;99(17):e19873. doi: 10.1097/MD.0000000000019873 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Ahmad N, Hassan Y, Tangiisuran B, Meng OL, Abd Aziz N, Ahmad F-D, et al. Guidelines adherence and hypertension control at a tertiary hospital in Malaysia. J Eval Clin Pract. 2013;19(5):798–804. doi: 10.1111/j.1365-2753.2012.01852.x [DOI] [PubMed] [Google Scholar]
PLOS Glob Public Health. doi: 10.1371/journal.pgph.0005818.r001

Decision Letter 0

Ilse Bloom

3 Mar 2026

PGPH-D-25-04043

Adherence to National Standard Treatment Guidelines in the Management of Hypertension and Associated Factors Among Healthcare Providers at Public District Hospitals in Dar es Salaam, Tanzania

PLOS Global Public Health

Dear Dr. MUNG'ONG'O,

Thank you for submitting your manuscript to PLOS Global Public Health. After careful consideration, we feel that it has merit but does not fully meet PLOS Global Public Health’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please note that we have only been able to secure a single reviewer to assess your manuscript. We are issuing a decision on your manuscript at this point to prevent further delays in the evaluation of your manuscript. Please be aware that the editor who handles your revised manuscript might find it necessary to invite additional reviewers to assess this work once the revised manuscript is submitted. However, we will aim to proceed on the basis of this single review if possible.

The comments from the reviewer can be found below and in the attached document. Please review these comments and make the appropriate revisions to your manuscript alongside a point-by-point response to the concerns raised.

Please submit your revised manuscript by Apr 17 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at globalpubhealth@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pgph/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A letter that responds to each point raised by the editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

We look forward to receiving your revised manuscript.

Kind regards,

Ilse Bloom

Staff Editor

PLOS Global Public Health

Journal Requirements:

1. Please upload a copy of Figure 1 and 2 which you refer to in your text on pages 10 and 13. Or, if the figure is no longer to be included as part of the submission please remove all reference to it within the text.

If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise.

Additional Editor Comments (if provided):

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

-->Comments to the Author

1. Does this manuscript meet PLOS Global Public Health’s publication criteria? Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe methodologically and ethically rigorous research with conclusions that are appropriately drawn based on the data presented.-->

Reviewer #1: Yes

**********

-->2. Has the statistical analysis been performed appropriately and rigorously?-->

Reviewer #1: Yes

**********

-->3. Have the authors made all data underlying the findings in their manuscript fully available (please refer to the Data Availability Statement at the start of the manuscript PDF file)?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception. The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.-->

Reviewer #1: Yes

**********

-->4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS Global Public Health does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.-->

Reviewer #1: Yes

**********

-->5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)-->

Reviewer #1: For all the manuscript, correct anti hypersive patient to people with hypertension

1. Abstract:

a) Material and Methods:

- Quantitative data from 397 patient files : It is already a result.Insert it among results.

- Why Poisson regression and not a linear one?

b) results

- there is no characteristics of people living with HTN

- add p-value on the regression results: aPR = 7.00; 95% CI: 3.08–15.92, p=

2. Introduction :

- Line 74: Giving that the HTN could reach 50% among adults in certain places, I would like to propose you to say that there is a discrepancy between urban and rural prevalence of HTN..

- Line 76 - 77: limited access to care is more global

- Line 91: specify which guidelines please

3. Materials and Methods

- Line 97 : No need to precise that is analytical, either you say that this study had 2 components…

- You stayed mixed methods, precise which one

- Line 110: outpatients departments or consultations?

- Line 111: all cadres ??? What do you want to say ? any type ???

- Line 118: i. All patients with Hypertension who were attended from January 2024 to December 2024 at the selected public district hospitals and have case file and agreeing to be part of the study.

ii. All healthcare providers in the public district hospitals who are taking part in the prescribe management of for Hypertensive patients with hypertension and agreeing to be part of the study

- Line 125: exclusion criteria. dis yiu include Pregnant women??? or Retraction from the study???

- Line 130 : You did have any minimum sample size???

- Line 134: I would have prefered that you have a structured questionnaire. qualitative interview are biased

- Line 165: what is ODK

- Line 208: what is ATLAS.ti ?-

4. results

- Figure 1: What were the inegilibility criteria?

- Line 262: You choose some healthcarer. Why and how did you choose them?

- Line 272: Pvalue ???

You gave the p-value for the follow-up visits, presents similarly grade &, 2 and 3 hypertension

- Presentation of barriers is too long 'almost 5 pages). Please try to reduce it

5. discussion:

- Line 129 : Comparable trends have been observed in other sub-Saharan African settings, including Ethiopia (19.5%), Ghana (30%), and Zimbabwe (35%) (28,30,31), where inadequate provider training and resource limitations were key barriers to adherence. Did these studies proved what are you stating?

- Line 143 : was also higher in management of patients with Grade 1 and 2. Is it not indicative of therapeutic inerty

- Line 153: Use the conditional tense. Be less assertive.

- Line 177 : Please cite Hypertension in Sub-Saharan Africa: Burden, Barriers and Priorities for Improving Treatment Outcomes Doi: 10.1161/CIRCRESAHA.124.323889

**********

-->6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

Do you want your identity to be public for this peer review?  If you choose “no”, your identity will remain anonymous but your review may still be made public.

For information about this choice, including consent withdrawal, please see our Privacy Policy.-->

Reviewer #1: Yes:  Sylvain Raoul SIMENI NJONNOU

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

-->Figure Resubmissions:

-->-->While revising your submission, we strongly recommend that you use PLOS’s NAAS tool (https://ngplosjournals.pagemajik.ai/artanalysis) to test your figure files. NAAS can convert your figure files to the TIFF file type and meet basic requirements (such as print size, resolution), or provide you with a report on issues that do not meet our requirements and that NAAS cannot fix.-->-->

After uploading your figures to PLOS’s NAAS tool - https://ngplosjournals.pagemajik.ai/artanalysis, NAAS will process the files provided and display the results in the "Uploaded Files" section of the page as the processing is complete. If the uploaded figures meet our requirements (or NAAS is able to fix the files to meet our requirements), the figure will be marked as "fixed" above. If NAAS is unable to fix the files, a red "failed" label will appear above. When NAAS has confirmed that the figure files meet our requirements, please download the file via the download option, and include these NAAS processed figure files when submitting your revised manuscript.-->

Attachment

Submitted filename: PGPH-D-25-04043_reviewer.docx

pgph.0005818.s001.docx (152.2KB, docx)
PLOS Glob Public Health. doi: 10.1371/journal.pgph.0005818.r003

Decision Letter 1

Ilse Bloom, Jennifer Tucker

21 Apr 2026

PGPH-D-25-04043R1

Adherence to National Standard Treatment Guidelines in the Management of Hypertension and Associated Factors Among Healthcare Providers at Public District Hospitals in Dar es Salaam, Tanzania

PLOS Global Public Health

Dear Dr. MUNG'ONG'O,

Thank you for submitting your manuscript to PLOS Global Public Health. After careful consideration, we feel that it has merit but does not fully meet PLOS Global Public Health’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

A single reviewer has recommended some additional revisions before your manuscript can be considered for publication. Please address all comments below in your revised submission.

Please submit your revised manuscript by May 20 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at globalpubhealth@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pgph/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A letter that responds to each point raised by the editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

As the corresponding author, your ORCID iD is verified in the submission system and will appear in the published article. PLOS supports the use of ORCID, and we encourage all coauthors to register for an ORCID iD and use it as well. Please encourage your coauthors to verify their ORCID iD within the submission system before final acceptance, as unverified ORCID iDs will not appear in the published article. Only  the individual author can complete the verification step; PLOS staff cannot  verify ORCID iDs on behalf of authors.

We look forward to receiving your revised manuscript.

Kind regards,

Jennifer Tucker, PhD

Staff Editor

PLOS Global Public Health

Journal Requirements:

1. Please amend your online Financial Disclosure statement. If you did not receive any funding for this study, please simply state: "The authors received no specific funding for this work."

2. Please update your online Competing Interests statement. If you have no competing interests to declare, please state: "The authors have declared that no competing interests exist."

3. We note your Data Availability statement as follows:

“Due to ethical restrictions related to patient confidentiality and protection of sensitive personal health information, the datasets generated and/or analyzed during the current study are not publicly available. De-identified quantitative data and relevant excerpts from qualitative interviews are available from the corresponding author upon reasonable request and with permission from the relevant ethics review committee.”

In this instance it seems there may be acceptable restrictions in place that prevent the public sharing of your minimal data. However, in line with our goal of ensuring long-term data availability to all interested researchers, PLOS’ Data Policy states that authors cannot be the sole named individuals responsible for ensuring data access (http://journals.plos.org/globalpublichealth/s/data-availability#loc-acceptable-data-sharing-methods).

Data requests to a non-author institutional point of contact, such as a data access or ethics committee, helps guarantee long term stability and availability of data. Providing interested researchers with a durable point of contact ensures data will be accessible even if an author changes email addresses, institutions, or becomes unavailable to answer requests.

Before we proceed with your manuscript, please also provide non-author contact information (phone/email/hyperlink) for a data access committee, ethics committee, or other institutional body to which data requests may be sent. If no institutional body is available to respond to requests for your minimal data, please consider if there any institutional representatives who did not collaborate in the study, and are not listed as authors on the manuscript, who would be able to hold the data and respond to external requests for data access? If so, please provide their contact information (i.e., email address). Please also provide details on how you will ensure persistent or long-term data storage and availability.

4. Please ensure that you cite or refer to Figures 1 and 2 in your text as, if accepted, production will need these references to link the reader to the figures.

5. Please ensure that you refer to your main Tables in your text as, if accepted, production will need these references to link the reader to the tables.

6. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise.

7. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments (if provided):

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

-->Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.-->

Reviewer #2: (No Response)

**********

-->2. Does this manuscript meet PLOS Global Public Health’s publication criteria? Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe methodologically and ethically rigorous research with conclusions that are appropriately drawn based on the data presented.-->

Reviewer #2: Yes

**********

-->3. Has the statistical analysis been performed appropriately and rigorously?-->

Reviewer #2: Yes

**********

-->4. Have the authors made all data underlying the findings in their manuscript fully available (please refer to the Data Availability Statement at the start of the manuscript PDF file)?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception. The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.-->

Reviewer #2: No

**********

-->5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS Global Public Health does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.-->

Reviewer #2: Yes

**********

-->6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)-->

Reviewer #2: The manuscript can be improved as follows:

1. The introduction contains useful points but is too long. It can be shortened and made to focus more on the problem that the manuscript attempts to answer, which is adherence to standard treatment guidelines.

2. Data analysis (P9, line 212)- The authors justify the use of the adherence cutoffs (e.g. 65% is good) based on prior studies that used the same cutoff. However this is a very low cutoff and there are data to show that this level of adherence would negatively affect patient outcomes. A better method should be considered or stronger justification for using these cutoffs.

3. Results

a. Line 279- please avoid using causal language in describing association between presence of comorbidities and receipt of guideline adherent care

b. Resource barriers P19- is it possible to quantify the resource barriers e.g. by systematically reporting level of availability of essential drugs and equipment in the participating hospitals? There are tools such as the WHO SARA tool that can be used to do this

**********

-->7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

Do you want your identity to be public for this peer review?  If you choose “no”, your identity will remain anonymous but your review may still be made public.

For information about this choice, including consent withdrawal, please see our Privacy Policy.-->

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

--> -->-->Figure Resubmissions:

-->-->While revising your submission, we strongly recommend that you use PLOS’s NAAS tool (https://ngplosjournals.pagemajik.ai/artanalysis) to test your figure files. NAAS can convert your figure files to the TIFF file type and meet basic requirements (such as print size, resolution), or provide you with a report on issues that do not meet our requirements and that NAAS cannot fix.-->-->

After uploading your figures to PLOS’s NAAS tool - https://ngplosjournals.pagemajik.ai/artanalysis, NAAS will process the files provided and display the results in the "Uploaded Files" section of the page as the processing is complete. If the uploaded figures meet our requirements (or NAAS is able to fix the files to meet our requirements), the figure will be marked as "fixed" above. If NAAS is unable to fix the files, a red "failed" label will appear above. When NAAS has confirmed that the figure files meet our requirements, please download the file via the download option, and include these NAAS processed figure files when submitting your revised manuscript.-->

PLOS Glob Public Health. doi: 10.1371/journal.pgph.0005818.r005

Decision Letter 2

Ilse Bloom, Jennifer Tucker, Julia Robinson

7 Jun 2026

Adherence to National Standard Treatment Guidelines in the Management of Hypertension and Associated Factors Among Healthcare Providers at Public District Hospitals in Dar es Salaam, Tanzania

PGPH-D-25-04043R2

Dear DR MUNG'ONG'O,

We are pleased to inform you that your manuscript 'Adherence to National Standard Treatment Guidelines in the Management of Hypertension and Associated Factors Among Healthcare Providers at Public District Hospitals in Dar es Salaam, Tanzania' has been provisionally accepted for publication in PLOS Global Public Health.

Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests.

Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated.

IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they'll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact globalpubhealth@plos.org.

Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Global Public Health.

Best regards,

Julia Robinson

Executive Editor

PLOS Global Public Health

***********************************************************

Reviewer Comments (if any, and for reference):

Reviewer's Responses to Questions

-->Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.-->

Reviewer #2: All comments have been addressed

**********

-->2. Does this manuscript meet PLOS Global Public Health’s publication criteria? Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe methodologically and ethically rigorous research with conclusions that are appropriately drawn based on the data presented.-->

Reviewer #2: (No Response)

**********

-->3. Has the statistical analysis been performed appropriately and rigorously?-->

Reviewer #2: (No Response)

**********

-->4. Have the authors made all data underlying the findings in their manuscript fully available (please refer to the Data Availability Statement at the start of the manuscript PDF file)?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception. The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.-->

Reviewer #2: (No Response)

**********

-->5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS Global Public Health does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.-->

Reviewer #2: (No Response)

**********

-->6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)-->

Reviewer #2: I am satisfied with the revisions to the manuscript

**********

-->7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

Do you want your identity to be public for this peer review?  If you choose “no”, your identity will remain anonymous but your review may still be made public.

For information about this choice, including consent withdrawal, please see our Privacy Policy.-->

Reviewer #2: Yes:  Anthony O. Etyang

**********

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    Attachment

    Submitted filename: PGPH-D-25-04043_reviewer.docx

    pgph.0005818.s001.docx (152.2KB, docx)
    Attachment

    Submitted filename: Response to reviewers.docx

    pgph.0005818.s003.docx (21.8KB, docx)
    Attachment

    Submitted filename: Response_to_reviewers_auresp_2.docx

    pgph.0005818.s004.docx (21.2KB, docx)

    Data Availability Statement

    Due to ethical restrictions related to patient confidentiality and protection of sensitive personal health information, the datasets generated and/or analyzed during the current study are not publicly available. De-identified quantitative data and relevant excerpts from qualitative interviews are available upon reasonable request and with permission from the MUHAS Research and Publications Committee, which granted ethical approval for this study (approval number DA.282/298/01.C/2694). Data requests may be directed to the MUHAS Research and Publications Committee, Muhimbili University of Health and Allied Sciences, P.O. Box 65001, Dar es Salaam, Tanzania (Email: rpc@muhas.ac.tz; Website: www.muhas.ac.tz). Data will be retained in accordance with MUHAS institutional data management policies ensuring long-term availability to interested researchers.


    Articles from PLOS Global Public Health are provided here courtesy of PLOS

    RESOURCES